Register now and explore groundbreaking advancements in acute leukemia and myelodysplasia treatment at ALF 2025. Stay informed with the latest innovations shaping the future of hematology/oncology research.
As 2024 comes to a close, Dermatology Times is taking a look back at the unique insights and updates shared by nurse practitioners and physician…
In this video, Amy J McMichael, MD, FAAD, discusses the complexities of diagnosis with alopecia areata (eg, differential diagnosis), the currently available disease severity assessment…
J Clin Aesthet Dermatol. 2024;17(12):16–17. by Roger I. Ceilley, MD, FAAD, FCMS, and Shandhan Sureshbabu, CDT Dr. Ceilley and Mr. Sureshbabu are with Dermatology P.C.…
Explore the top dermatology news of 2024, highlighting breakthroughs, innovations, and key clinical insights shaping the future of skin care and treatment.
Explore the standout moments and expert insights from Dermatology Times’ Cutaneous Connection podcast episodes in 2024.
This study using data from 3 phase 3 randomized clinical trials evaluates the efficacy and adverse events of upadacitinib in adolescent patients with moderate to…
Register now and explore groundbreaking advancements in acute leukemia and myelodysplasia treatment at ALF 2025. Stay informed with the latest innovations shaping the future of…
Sponsored by Novartis Pharmaceuticals Corporation Sponsored by Novartis Pharmaceuticals Corporation, this video series provides expert perspectives on the patient burden, diagnostic challenges, disease severity, treatment…
This cohort study aims to define the spectrum of cutaneous manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome and the association of these…
This cohort study investigates nail abnormality prevalence among patients with (BRCA1-associated protein) BAP1 tumor predisposition syndrome.
